Pharmacokinetics Of Azithromycin Immediate Release And Extended Release Formulation In Kids With Acute Otitis Media

Registry ID

EUCTR2014-004164-38

Source registry

EUCTR

Phase

PHASE2

Sponsor

Pfizer Inc

Last update

2026-08-16

Conditions

• Acute otitis media

Summary

To compare the pharmacokinetics of azithromycin following a single dose of either 30 milligram per kilogram (mg/kg) IR or 60 mg/kg ER formulation in pediatric subjects with AOM.

View on source registry